BOSTON--(BUSINESS WIRE)--ZappRx®, a healthcare technology company that streamlines the complex processes associated with prescribing specialty medications, announced today that it will work with Teva Respiratory, LLC, in support of their specialty respiratory medication. The joint project will provide a more efficient approach to prescribe, obtain, and administer therapy necessary for patients to better manage their disease and symptoms.
“By partnering with industry leaders such as Teva Respiratory, ZappRx is able to make life-changing medications more accessible to an underserved patient population,” said Zoë Barry, CEO and Founder of ZappRx. “ZappRx is committed to helping patients first and foremost, and we are confident that working with Teva will help us to do exactly that.”
ZappRx’s cloud-based platform streamlines what is currently a multi-step, manual prescribing process, often involving numerous platforms for each of several treatments, into a single, digitally-enabled format. This allows providers who treat severe asthma to focus more on patient care.
To learn more about ZappRx and the work it is doing to improve care for patients in need, visit them online at www.zapprx.com.
About ZappRx
ZappRx streamlines the complex process required
to order specialty medications, increasing efficiencies when collecting
and maintaining the myriad requisite information for ordering specialty
drugs — including pharmacy information, payer/prior authorization
requirements, and relevant clinical history. ZappRx then enables
providers, pharmacists, and payers to digitally interact with one
another to fill a prescription, reducing the need for faxes and phone
calls. The platform currently is live in Pulmonary (including Cystic
Fibrosis (CF), Pulmonary Arterial Hypertension (PAH), and Idiopathic
Pulmonary Fibrosis (IPF)), Severe Asthma, Cardiology (including
Hyperlipidemia and Congestive Heart Failure), and Gastroenterology
(including Crohn’s Disease and Ulcerative Colitis). As the company
grows, ZappRx plans to expand into other areas, including Rheumatology,
Neurology, and Oncology.
Connect with ZappRx on Twitter and LinkedIn.
ZappRx and the "Z" logo are registered trademarks of ZappRx, Inc.
